Development and validation of a cell-based assay system to assess human immunodeficiency virus type 1 integrase

Tomofumi Nakamura1, Joseph R Campbell1, Amber R Moore1

  • 1Departments of Infectious Diseases and Hematology, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.

Summary

Disrupting HIV-1 integrase multimerization offers a new HIV intervention strategy. A novel bimolecular fluorescence complementation (BiFC-IN) assay effectively monitors integrase multimerization and aids in discovering new drugs.

Related Concept Videos